Unresectable / Advanced Hepatocellular Cancer

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
13:25

14th International Gastrointestinal Cancers Conference (IGICC2024)

Management of Fibrolamellar Liver Cancer

FEATURING Sunyoung Lee
  • 9 views
  • April 9, 2025
19:34

The France Foundation

Guidelines for Assessment and Management for Advanced HCC

FEATURING Katie Kelley
  • 37 views
  • April 3, 2025
  • 1
17:43

The France Foundation

Data Summary and Update on Preferred Immunotherapies for Advanced HCC

FEATURING Adam Burgoyne, Katie Kelley
  • 9 views
  • April 3, 2025
13:00

The France Foundation

Multidisciplinary Case Considerations & Discussions: Advanced HCC Patient With Cirrhosis, Portal HTN, and Esophageal Varices

FEATURING Adam Burgoyne, Katie Kelley
  • 7 views
  • April 3, 2025
23:22

COR2ED The Heart of Medical Education

Advanced HCC Panel Discussion: The Use of IO in Unresectable HCC + Safety and Efficacy of IO & IO Combinations

FEATURING Rachna Shroff, Rohit Gosain, Rahul Gosain
  • 6 views
  • March 28, 2025
26:19

COR2ED The Heart of Medical Education

Advanced HCC Panel Discussion: 2L Treatment Selection and When to Switch

FEATURING Lorenza Rimassa, Arndt Vogel, Rohit Gosain, Rahul Gosain
  • 4 views
  • March 28, 2025
04:54

COR2ED The Heart of Medical Education

Use of IO in Unresectable HCC: Safety & Efficacy of IO & IO Combinations

FEATURING Rachna Shroff, Rohit Gosain, Rahul Gosain
  • 2 views
  • March 28, 2025
05:36

COR2ED The Heart of Medical Education

Integrating Multimodal Approaches With Multidisciplinary Care for Intermediate HCC

FEATURING Rohit Gosain, Rahul Gosain, Mark Yarchoan, Nina Sanford, Edward Kim
  • 12 views
  • March 10, 2025
27:13

COR2ED The Heart of Medical Education

Multidisciplinary Panel Discussion: Integrating IO Into the Management of Intermediate HCC

FEATURING Rohit Gosain, Rahul Gosain, Mark Yarchoan, Nina Sanford, Edward Kim
  • 19 views
  • March 10, 2025
19:15

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Key Trial Highlights in Hepatobiliary Cancer - ACCELERATE, RACB & CheckMate 9DW

FEATURING Richard Kim, Tiago Biachi
  • 146 views
  • March 7, 2025
05:16

Laura Dawson

SBRT vs. Sorafenib Alone in HCC - Ph3 ENERGY 1112 Trial Results

  • 17 views
  • March 6, 2025
05:19

COR2ED The Heart of Medical Education

Advanced HCC: 2L Treatment Selection & When to Switch

FEATURING Lorenza Rimassa, Arndt Vogel, Rohit Gosain, Rahul Gosain
  • 40 views
  • March 6, 2025
  • 2
04:53

COR2ED The Heart of Medical Education

Intermediate HCC: Clinical Considerations & Multidisciplinary Collaboration

FEATURING Emil Cohen, Rohit Gosain, Rahul Gosain
  • 8 views
  • March 6, 2025
15:58

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Intermediate HCC and the Management of Liver Disease

FEATURING Maria Reig
  • 90 views
  • March 4, 2025
  • 1
19:30

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Development and FDA Approval of a Novel Systemic Targeted Delivery of Radiofrequency Electromagnetic Fields for Advanced R/R HCC

FEATURING Boris Pasche
  • 61 views
  • February 28, 2025
04:11

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Camrelizumab + Rivoceranib vs. Sorafenib for 1L Unresectable HCC of Viral and Non-Viral Etiology - Ph3 CARES-310 Trial

FEATURING Rachna Shroff
  • 65 views
  • February 25, 2025
06:51

14th International Gastrointestinal Cancers Conference (IGICC2024)

Characteristics & Prognostic Factors of HBV Associated HCC in Patients With & Without Cirrhosis

FEATURING Ibrahim Emir Tekin
  • 3 views
  • February 25, 2025
20:03

14th International Gastrointestinal Cancers Conference (IGICC2024)

Optimal Sequencing of Systemic Treatment for HCC

FEATURING Sahin Lacin
  • 16 views
  • February 25, 2025
16:59

14th International Gastrointestinal Cancers Conference (IGICC2024)

Optimizing Radiation Therapy for HCC

FEATURING Enis ÖZyar
  • 20 views
  • February 25, 2025
09:15

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Pt Characteristics, Treatment Patterns, and Survival Outcomes in Unresectable HCC Treated With 1L Systemic Therapy in the US

FEATURING Nguyen Tran
  • 82 views
  • February 12, 2025
10:36

The France Foundation

Multidisciplinary Tumor Board Case: Pt With MAFLD, Child-Pugh B Cirrhosis, Post-HCV Treatment and HCC

FEATURING Osman Ahmed, Anjana A. Pillai, Joseph Franses
  • 19 views
  • February 7, 2025
07:37

The France Foundation

Multidisciplinary Tumor Board Case: Pt With Alcohol-Associated, Child-Pugh A Cirrhosis and HCC - Systemic Therapy and IO Approach

FEATURING Osman Ahmed, Anjana A. Pillai, Joseph Franses
  • 109 views
  • February 7, 2025
12:16

The France Foundation

Multidisciplinary Tumor Board Case: Pt With PMH of HBV and Mixed HCC-Cholangiocarcinoma - From Surgical Resection to Systemic Therapy

FEATURING Osman Ahmed, Anjana A. Pillai, Joseph Franses
  • 10 views
  • February 7, 2025
07:14

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Real-World Experience With Atezo + Bev in Unresectable HCC - A Multicenter Study

FEATURING Maen Abdelrahim
  • 191 views
  • February 6, 2025
18:41

14th International Gastrointestinal Cancers Conference (IGICC2024)

Overview of Key Immunotherapy Trials in Advanced HCC

FEATURING Vladimir Nikolic
  • 75 views
  • February 5, 2025

Unresectable / Advanced Hepatocellular Cancer

No subtopics